Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study

Author： Cerchietti L.C.A.   Navigante A.H.   Peluffo G.D.   Diament M.J.   Stillitani I.   Klein S.A.   Cabalar M.E.  

Publisher： Elsevier

ISSN： 0885-3924

Source： Journal of Pain and Symptom Management, Vol.27, Iss.1, 2004-01, pp. : 85-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical study on gefitinib combined with γray stereotactic body radiation therapy as the firstline treatment regimen for senile patients with adenocarcinoma of the lung (final results of JLY20080085)

By        

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 711-715

Spandidos Publications

Access to resources Recommend Favorite

Nickel sensitization and dietary nickel are a substantial cause of symptoms provocation in patients with chronic allergic-like dermatitis syndromes

By Antico Andrea   Soana Roberto  

Allergy & Rhinology, Vol. 6, Iss. 1, 2015-01 ,pp. : e56-e63

OceanSide Publications, Inc

Access to resources Recommend Favorite

Clinical and Immunomodulatory Effects of Celecoxib Plus Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients with COX-2 Tumor Immunostaining

By Schwandt Anita  

Journal of Clinical Immunology, Vol. 31, Iss. 4, 2011-08 ,pp. : 690-698

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 449-453

Spandidos Publications

Access to resources Recommend Favorite

Over-Expression of Egfr is Closely Correlated to Poor Prognosis in Tunisian Patients with Non-Small Cell Lung Adenocarcinoma

By              

Journal of Immunoassay and Immunochemistry, Vol. 35, Iss. 3, 2014-07 ,pp. : 256-268

Taylor & Francis Ltd

Access to resources Recommend Favorite